KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Debt Ratio (2016 - 2025)

Emergent BioSolutions' Debt Ratio history spans 16 years, with the latest figure at 0.43 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 9.15% year-over-year to 0.43; the TTM value through Dec 2025 reached 0.43, down 9.15%, while the annual FY2025 figure was 0.43, 9.15% down from the prior year.
  • Debt Ratio reached 0.43 in Q4 2025 per EBS's latest filing, down from 0.45 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.48 in Q4 2024 to a low of 0.14 in Q4 2022.
  • Average Debt Ratio over 5 years is 0.32, with a median of 0.29 recorded in 2021.
  • Peak YoY movement for Debt Ratio: crashed 48.24% in 2022, then surged 95.01% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.27 in 2021, then plummeted by 48.24% to 0.14 in 2022, then skyrocketed by 72.89% to 0.24 in 2023, then soared by 95.01% to 0.48 in 2024, then dropped by 9.15% to 0.43 in 2025.
  • Per Business Quant, the three most recent readings for EBS's Debt Ratio are 0.43 (Q4 2025), 0.45 (Q3 2025), and 0.47 (Q2 2025).